Laurie McWilliams, MD
Allergy & Immunology · Raleigh, NCNPI 1699942714
Payments from drug & device makers
Across 773 payments — averaging $200.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$69K
- GSK$57K
- Boehringer Ingelheim$10K
- Chiesi USA, Inc.$8K
- AstraZeneca$3K
- Genentech USA, Inc.$1K
- plus $6K from 26 others
Across 4 payments — averaging $888.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 395 | $68,930 |
| GSK | 80 | $56,939 |
| Boehringer Ingelheim | 11 | $10,219 |
| Chiesi USA, Inc. | 8 | $8,070 |
| AstraZeneca | 34 | $3,071 |
| Genentech USA, Inc. | 9 | $1,494 |
| Sanofi US Services Inc. | 2 | $1,272 |
| Regeneron Healthcare Solutions, Inc. | 49 | $1,046 |
| Amgen | 83 | $821 |
| Sanofi | 23 | $679 |
| Novartis | 8 | $289 |
| Grifols USA, LLC | 6 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $230 |
| CSL Behring | 7 | $211 |
| Sanofi-aventis U.S. LLC | 3 | $205 |
| Aimmune Therapeutics, Inc. | 2 | $190 |
| Pfizer | 8 | $162 |
| Galderma Laboratories, L.p. | 3 | $136 |
| Kaleo, Inc. | 8 | $124 |
| Genentech, Inc. | 2 | $124 |
| AbbVie | 6 | $123 |
| Blueprint Medicines Corporation | 1 | $107 |
| Alk-abello, Inc | 3 | $56 |
| Lilly USA, LLC | 2 | $46 |
| Optinose US, Inc. | 2 | $37 |
| Phadia US Inc. | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Biocryst US Sales Co., LLC | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Circassia Inc. | 1 | $19 |
| Merck | 1 | $12 |
How this compares
$154,965 in reported general payments places this provider in the 85th percentile of 140 allergy & immunology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Raleigh
- Craig LaforceRaleigh$7.9M
- Karen DunnRaleigh$3.3M
- Jonathan RomeoRaleigh$280K
- Sonia BainsRaleigh$23K
- Gurvinder DeogunRaleigh$14K
- Maureen PetersenRaleigh$13K
- Heather GutekunstRaleigh$12K
- Maeve OconnorCharlotte$2.2M
- David CypcarAsheville$1.6M
- Edwin KimChapel Hill$874K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.